We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

17 hedge funds and large institutions have $3.66M invested in Bio-Path Holdings Inc in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

6% less funds holding

Funds holding: 18 → 17 (-1)

20% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 5

41% less capital invested

Capital invested by funds: $6.22M → $3.66M (-$2.56M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
4
Increased
4
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$315K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$220K
3
Millennium Management
Millennium Management
New York
+$159K
4
SWP
Stratos Wealth Partners
Ohio
+$159K
5
BlackRock
BlackRock
New York
+$111K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$663K
2
Two Sigma Investments
Two Sigma Investments
New York
-$504K
3
VF
Virtu Financial
New York
-$336K
4
G
Gainplan
Michigan
-$204K
5
Barclays
Barclays
United Kingdom
-$43K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$1.62M -$663K -2,090 -26%
BlackRock
2
BlackRock
New York
$628K +$111K +349 +17%
Vanguard Group
3
Vanguard Group
Pennsylvania
$374K +$41.2K +130 +10%
Morgan Stanley
4
Morgan Stanley
New York
$267K +$315K +993 +19,860%
UOTTAIMCU
5
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$256K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$185K +$220K +694 New
Millennium Management
7
Millennium Management
New York
$134K +$159K +500 New
SWP
8
Stratos Wealth Partners
Ohio
$134K +$159K +500 New
UBS Group
9
UBS Group
Switzerland
$24K +$3.81K +12 +15%
LTFS
10
Ladenburg Thalmann Financial Services
Florida
$14K – – –
Wells Fargo
11
Wells Fargo
California
$7K -$9.51K -30 -53%
SL
12
Salomon & Ludwin
Virginia
$7K +$8.24K +26 New
AG
13
Advisor Group
Arizona
$4K -$2.22K -7 -32%
CAPTRUST Financial Advisors
14
CAPTRUST Financial Advisors
North Carolina
$3K – – –
AF
15
Advisornet Financial
Minnesota
$1K – – –
BNP Paribas Financial Markets
16
BNP Paribas Financial Markets
France
$13 – – –
Two Sigma Investments
17
Two Sigma Investments
New York
– -$504K -1,236 Closed
VF
18
Virtu Financial
New York
– -$336K -823 Closed
G
19
Gainplan
Michigan
– -$204K -500 Closed
Barclays
20
Barclays
United Kingdom
– -$43K -105 Closed
WAM
21
Wealthspire Advisors (Maryland)
Maryland
– -$2K -5 Closed

BPTH Hedge Fund Activity: Q2 2019 in Review

17 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q2 2019, worth a combined $3.66M — down 41% from $6.22M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of BPTH and 4 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 4 added.

The largest buyer was Morgan Stanley, adding an estimated $315K. The largest seller was Renaissance Technologies, cutting an estimated $663K.

  • 17 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q2 2019, down from 18 in Q1 2019.
  • Funds reported $3.66M of Bio-Path Holdings Inc stock for Q2 2019, down 41% quarter-over-quarter.
  • 4 funds opened new Bio-Path Holdings Inc positions in Q2 2019 and 5 closed out, a net change of -1 holder.
  • The largest Bio-Path Holdings Inc buyer in Q2 2019 was Morgan Stanley, an estimated $315K added.
  • The largest Bio-Path Holdings Inc seller in Q2 2019 was Renaissance Technologies, an estimated $663K sold.

Based on aggregated 13F filings for Q2 2019.